Arend SM - Search Results

1

Editorial commentary: genotyping of Mycobacterium tuberculosis in China and missing links in the chain of ongoing transmission of tuberculosis.

Arend SM, van Soolingen D. Arend SM, et al. Clin Infect Dis. 2015 Jul 15;61(2):228-32. doi: 10.1093/cid/civ259. Epub 2015 Mar 31. Clin Infect Dis. 2015. PMID: 25829002 No abstract available.

2

Performance of Xpert MTB/RIF Ultra: a matter of dead or alive.

Arend SM, van Soolingen D. Arend SM, et al. Lancet Infect Dis. 2018 Jan;18(1):8-10. doi: 10.1016/S1473-3099(17)30695-3. Epub 2017 Dec 5. Lancet Infect Dis. 2018. PMID: 29198910 Free article. No abstract available.

3

Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.

Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff TH, van Dissel JT. Arend SM, et al. J Infect Dis. 2002 Dec 15;186(12):1797-807. doi: 10.1086/345760. Epub 2002 Nov 19. J Infect Dis. 2002. PMID: 12447766

4

ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii.

Arend SM, de Haas P, Leyten E, Rosenkrands I, Rigouts L, Andersen P, Mijs W, van Dissel JT, van Soolingen D. Arend SM, et al. J Infect Dis. 2005 Apr 15;191(8):1301-10. doi: 10.1086/428950. Epub 2005 Mar 15. J Infect Dis. 2005. PMID: 15776377 Free article.

5

Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?

Arend SM, van Soolingen D. Arend SM, et al. Clin Infect Dis. 2011 Jan 1;52(1):89-93. doi: 10.1093/cid/ciq016. Clin Infect Dis. 2011. PMID: 21148525 No abstract available.

6

Tuberculosis after a borderline QuantiFERON result during screening before infliximab.

Uzorka JW, Delfos NM, Witte AMC, Scheper H, van Soolingen D, Arend SM. Uzorka JW, et al. Among authors: arend sm. Eur Respir J. 2018 Aug 2;52(2):1800913. doi: 10.1183/13993003.00913-2018. Print 2018 Aug. Eur Respir J. 2018. PMID: 30072541 Free article. No abstract available.

7

Diagnosis and treatment of lung infection with nontuberculous mycobacteria.

Arend SM, van Soolingen D, Ottenhoff TH. Arend SM, et al. Curr Opin Pulm Med. 2009 May;15(3):201-8. doi: 10.1097/MCP.0b013e3283292679. Curr Opin Pulm Med. 2009. PMID: 19305349 Review.

8

Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands.

Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG, van Dissel JT. Haverkamp MH, et al. Among authors: arend sm. Clin Infect Dis. 2004 Aug 15;39(4):450-6. doi: 10.1086/422319. Epub 2004 Jul 23. Clin Infect Dis. 2004. PMID: 15356803

9

A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.

Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT. Arend SM, et al. Clin Infect Dis. 2007 Dec 1;45(11):1470-5. doi: 10.1086/522993. Epub 2007 Oct 25. Clin Infect Dis. 2007. PMID: 17990230

10

To Bridge, Blossom, or Boost: That Is the Question.

Arend SM, Jedema I. Arend SM, et al. Clin Infect Dis. 2020 Mar 17;70(7):1438-1441. doi: 10.1093/cid/ciz370. Clin Infect Dis. 2020. PMID: 31067571 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters